申请人:Takeda Chemical Industries, Ltd.
公开号:US06235731B1
公开(公告)日:2001-05-22
A novel compound of the formula:
wherein ring Q is an optionally substituted pyridine ring;
One of R0, R1 and R2 is —Y0—Z0, and the other tow groups are a hydrogen, a halogen, an optionally substituted hydroxy group, a hydrocarbon group that may be an optionally substituted hydrocarbon group or an acyl group;
Y0 is a bond or an optionally substituted bivalent hydrocarbon group;
Z0 is a basic group which may be bonded via oxygen, nitrogen, —CO—, —CS—, —SO2N(R3)— (where R3 is hydrogen or an optionally substituted hydrocarbon group), or S(O)n (wherein n is to 0, 1 or 2);
......... is a single bond or a double bond, or a salt thereof, which has an excellent LDL receptor up-regulating, blood-lipids lowering, blood-sugar lowering and diabetic complication-ameliorating activity.
其中环Q是一个可选择取代的吡啶环;
R0、R1和R2中的一个是—Y0—Z0,另外两个基团是氢、卤素、可选择取代的羟基、可能是可选择取代的碳氢基团或酰基;
Y0是一个键或一个可选择取代的二价碳氢基团;
Z0是一种碱性基团,可以通过氧、氮、—CO—、—CS—、—SO2N(R3)—(其中R3是氢或可选择取代的碳氢基团)或S(O)n(其中n为0、1或2)与之键合;
.........是一种单键或双键,或其盐,具有出色的LDL受体上调、降低血脂、降低血糖和改善糖尿病并发症的活性。